retatrutide first week ๐จBreaking: Retatrutide's Phase 3 T2D data just dropped. โธ A1C: โ2.0% at 40 weeks โธ Weight: โ36.6 lbs (โ16.8%) at 12 mg โธ No weight loss plateau โ curve still descending What Is the Starting Dose
Description
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
In particular, conclusions regarding pancreatic cancer risk remain limited by low GRADE certainty, wide confidence intervals, and heterogeneous outcome definitions
The lack of mechanistic overlap also means you are not doubling up on the same side effects
Retatrutides side effect profile is similar to other drugs in its class
Its also the target of popular weight loss medications like Ozempic and Wegovy
Cancers, 17(16), 2600
